Pharmaceutical Biocatalysis

Important Enzymes, Novel Targets, and Therapies
Herausgeber: Grunwald, Peter

• Gebundenes Buch

Produktbeschreibung

This volume of Pharmaceutical Biocatalysis starts with a discussion on the importance of biocatalytic synthesis approaches for a sustainable and environmentally friendly production of pharmaceuticals and active pharmaceutical ingredients.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Jenny Stanford Series on Biocatalysis
• Verlag: Jenny Stanford Publishing
• Seitenzahl: 480
• Erscheinungstermin: 2. November 2020
• Englisch
• Abmessung: 235mm x 157mm x 30mm
• Gewicht: 880g
• ISBN-13: 9789814877138
• ISBN-10: 9814877131
• Artikelnr.: 60022997

Autorenporträt

Peter Grunwald studied chemistry at the Universities of Saarbrücken and Hamburg, Germany. He graduated in the field of high-frequency spectroscopy and then became a staff member of the Institute of Physical Chemistry. After receiving his PhD in physical chemistry, he founded a biotechnology research group. He was appointed professor in 2001. His research interests focus on immobilized biocatalysts, kinetics of enzymes in organic solvents, and interactions between biocatalysts and heavy metal ions. Prof. Grunwald is also interested in chemical education, including curriculum development. He has authored a textbook on biochemistry and is an editorial board member of Catalysts.

Inhaltsangabe

Lipase-Mediated Biocatalysis as a Greener and Sustainable Choice for
Pharmaceutical Processes. Phosphodiesterases. Human DOPA Decarboxylase:
Catalysis and Involvement in Pharmacological Treatments for Parkinson's
Disease and Aromatic Amino Acid Decarboxylase Deficiency. Advancing
Phospholipase D Enzymes as Diverse Drug Targets. IDH1 and IDH2 Mutations as
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML): Current
Perspectives. Enzymes for Prodrug-Activation in Cancer Treatment and Gene
Therapies. Small-Molecule Inhibitors Targeting Receptor Tyrosine Kinases in
Cancer. ß-Lactams and Related Compounds as Antibacterials and ß-Lactamase
Inhibitors. Non-Vitamin K Oral Anticoagulants (NOACs): New Options.
Molecular Mechanisms for Statin Pleiotropy and Possible Clinical Relevance
in Cardiovascular Disease. Lysosomal Storage Disorders and Enzyme
Replacement Therapy.